Copy
Stronger Health Systems. Greater Health Impact.
View in browser  |  Share with a friend  |  Subscribe
MSH Global Health Impact

Don’t let Covid boost another killer

The pandemic may be interfering with our fight against drug-resistant bacteria. Luckily, the same tactics can beat back both scourges, writes Dr. Mohan P. Joshi, technical lead for antimicrobial resistance and global health security at MSH, in a recent opinion article for Knowable Magazine.  

Programs that aim to enhance appropriate use of antibiotics are a key component of the World Health Organization’s Global Action Plan to fight antimicrobial resistance. But during the pandemic, health facilities’ plans to educate and monitor staff have often fallen by the wayside. So, too, have efforts to maintain surveillance and quality-control programs to beat back resistant pathogens.

Overburdened as they are, health care facilities have to recognize that efforts against both COVID-19 and antimicrobial resistance will work in tandem. Fighting one with surveillance, education, and research will also help the other.

Read the article
Copyright © 2021 Management Sciences for Health, All rights reserved.
Follow us on Twitter Follow us on Twitter
Join us on LinkedIn Join us on LinkedIn
Global Health Impact Blog Global Health Impact Blog
Medium Medium
Like us on Facebook Like us on Facebook
Watch us on YouTube Watch us on YouTube